The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice
Open accessAbstract
Neuromyelitis optica is an inflammatory demyelinating disease of the central nervous system associated with autoantibodies against the glial water channel protein aquaporin-4. It has recently been reported that immunoglobulin from neuromyelitis optica patients injected peripherally does not cause lesions in naive rats, but only when pre-existing central nervous system inflammation is present. Here, we investigated whether immunoglobulin G from aquaporin-4-autoantibody-positive neuromyelitis optica patients has the potential to damage the central nervous system either alone or in the presence of human complement. Immunoglobulin G from neuromyelitis optica patients did not activate mouse complement and was not pathogenic when injected into mouse brain. However, co-injection of immunoglobulin G from neuromyelitis optica patients with human complement produced neuromyelitis optica-like lesions in mice. Within 12 h of co-injecting immunoglobulin G from neuromyelitis optica patients and human complement, there was a striking loss of aquaporin-4 expression, glial cell oedema, myelin breakdown and axonal injury, but little intra-parenchymal inflammation. At 7 days, there was extensive inflammatory cell infiltration, perivascular deposition of activated complement components, extensive demyelination, loss of aquaporin-4 expression, loss of reactive astrocytes and neuronal cell death. In behavioural studies, mice injected with immunoglobulin G from neuromyelitis optica patients and human complement into the right hemisphere preferentially turned to the right at 7 days. No brain inflammation, demyelination or right-turning behaviour was seen in wild-type mice that received immunoglobulin G from non-neuromyelitis optica patients with human complement, or in aquaporin-4-null mice that received immunoglobulin G from neuromyelitis optica patients with human complement. We conclude that co-injection of immunoglobulin G from neuromyelitis optica patients with human complement reproduces the key histological features of neuromyelitis optica and that aquaporin-4 is necessary and sufficient for immunoglobulin G from neuromyelitis optica patients to exert its effect. In our mouse model, immunoglobulin G from neuromyelitis optica patients does not require pre-existing central nervous system inflammation to produce lesions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
Lennon, V. A., Kryzer, T. J., Pittock, S. J., Verkman, A. S., & Hinson, S. R. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050304 · Cited by 2,288 · cited 15×
“This clinical observation supports our experimental finding that all parts of the CNS parenchyma that express AQP4 are vulnerable to neuromyelitis optica.”
BackgroundInfluentialSelf-citationThe spectrum of neuromyelitis optica
Wingerchuk, D. M., Lennon, V. A., Lucchinetti, C. F., Pittock, S. J., & Weinshenker, B. G. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70216-8 · Cited by 2,179
A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica
Lucchinetti, C. F. (2002) · Brain · doi:10.1093/brain/awf151 · Cited by 1,210
Impairment of angiogenesis and cell migration by targeted aquaporin-1 gene disruption
Saadoun, S., Papadopoulos, M. C., Hara-Chikuma, M., & Verkman, A. S. (2005) · Nature · doi:10.1038/nature03460 · Cited by 728
Self-citationRoemer, S. F., Parisi, J. E., Lennon, V. A., Benarroch, E. E., Lassmann, H., Bruck, W., Mandler, R. N., Weinshenker, B. G., Pittock, S. J., Wingerchuk, D. M., et al. (2007) · Brain · doi:10.1093/brain/awl371 · Cited by 716
Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre
Takahashi, T., Fujihara, K., Nakashima, I., Misu, T., Miyazawa, I., Nakamura, M., Watanabe, S., Shiga, Y., Kanaoka, C., Fujimori, J., et al. (2007) · Brain · doi:10.1093/brain/awm062 · Cited by 633
Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis
Misu, T., Fujihara, K., Kakita, A., Konno, H., Nakamura, M., Watanabe, S., Takahashi, T., Nakashima, I., Takahashi, H., & Itoyama, Y. (2007) · Brain · doi:10.1093/brain/awm047 · Cited by 614
Intrathecal pathogenic anti–aquaporin‐4 antibodies in early neuromyelitis optica
Bennett, J. L., Lam, C., Kalluri, S. R., Saikali, P., Bautista, K., Dupree, C., Glogowska, M., Case, D., Antel, J. P., Owens, G. P., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21802 · Cited by 590
Neuromyelitis optica: Pathogenicity of patient immunoglobulin in vivo
Bradl, M., Misu, T., Takahashi, T., Watanabe, M., Mader, S., Reindl, M., Adzemovic, M., Bauer, J., Berger, T., Fujihara, K., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21837 · Cited by 563
Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica
Hinson, S. R., Pittock, S. J., Lucchinetti, C. F., Roemer, S. F., Fryer, J. P., Kryzer, T. J., & Lennon, V. A. (2007) · Neurology · doi:10.1212/01.wnl.0000289761.64862.ce · Cited by 494
Ma, T., Yang, B., Gillespie, A., Carlson, E. J., Epstein, C. J., & Verkman, A. S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci231 · Cited by 450
Self-citationAntibody to aquaporin-4 in the long-term course of neuromyelitis optica
Jarius, S., Aboul-Enein, F., Waters, P., Kuenz, B., Hauser, A., Berger, T., Lang, W., Reindl, M., Vincent, A., & Kristoferitsch, W. (2008) · Brain · doi:10.1093/brain/awn240 · Cited by 435
Self-citationWater movements in the brain: role of aquaporins
Tait, M. J., Saadoun, S., Bell, B. A., & Papadopoulos, M. C. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2007.11.003 · Cited by 338
Self-citationMechanisms of Disease: aquaporin-4 antibodies in neuromyelitis optica
Jarius, S., Paul, F., Franciotta, D., Waters, P., Zipp, F., Hohlfeld, R., Vincent, A., & Wildemann, B. (2008) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0764 · Cited by 335
Self-citationNeuromyelitis optica: Passive transfer to rats by human immunoglobulin
Kinoshita, M., Nakatsuji, Y., Kimura, T., Moriya, M., Takata, K., Okuno, T., Kumanogoh, A., Kajiyama, K., Yoshikawa, H., & Sakoda, S. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.06.085 · Cited by 249
Greatly improved neurological outcome after spinal cord compression injury in AQP4-deficient mice
Saadoun, S., Bell, B. A., Verkman, A. S., & Papadopoulos, M. C. (2008) · Brain · doi:10.1093/brain/awn014 · Cited by 187
Self-citationIto, S., Mori, M., Makino, T., Hayakawa, S., & Kuwabara, S. (2009) · Annals of Neurology · doi:10.1002/ana.21753 · Cited by 161
Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: current status of the assays.
Waters, P. J., & Vincent, A. C. (2008) · PubMed · Cited by 127
Self-citationAQP4 gene deletion in mice does not alter blood–brain barrier integrity or brain morphology
Saadoun, S., Tait, M. J., Reza, A., Davies, D. C., Bell, B. A., Verkman, A. S., & Papadopoulos, M. C. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.03.069 · Cited by 126
Self-citationRash, J. E., & Yasumura, T. (1999) · Cell and Tissue Research · doi:10.1007/s004410051291 · Cited by 114
Astrocytic necrosis is induced by anti-aquaporin-4 antibody-positive serum
Kinoshita, M., Nakatsuji, Y., Moriya, M., Okuno, T., Kumanogoh, A., Nakano, M., Takahashi, T., Fujihara, K., Tanaka, K., & Sakoda, S. (2009) · Neuroreport · doi:10.1097/wnr.0b013e32832776f4 · Cited by 110
NMO‐IgG: A Specific Biomarker for Neuromyelitis Optica
Weinshenker, B. G., Wingerchuk, D. M., Pittock, S. J., Lucchinetti, C. F., & Lennon, V. A. (2006) · Disease Markers · doi:10.1155/2006/586306 · Cited by 94
Cited by
Development, maintenance and disruption of the blood-brain barrier
Obermeier, B., Daneman, R., & Ransohoff, R. M. (2013) · Nature Medicine · doi:10.1038/nm.3407 · Cited by 2,452
von Büdingen, H.-C., Palanichamy, A., Lehmann-Horn, K., Michel, B. A., & Zamvil, S. S. (2015) · European Neurology · doi:10.1159/000377675 · Cited by 1,463
Astrocyte barriers to neurotoxic inflammation
Sofroniew, M. V. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3898 · Cited by 1,202
Eculizumab in Aquaporin-4–Positive Neuromyelitis Optica Spectrum Disorder
Pittock, S. J., Berthele, A., Fujihara, K., Kim, H. J., Levy, M., Palace, J., Nakashima, I., Terzi, M., Totolyan, N., Viswanathan, S., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1900866 · Cited by 872
Jarius, S., Ruprecht, K., Wildemann, B., Kuempfel, T., Ringelstein, M., Geis, C., Kleiter, I., Kleinschnitz, C., Berthele, A., Brettschneider, J., et al. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-14 · Cited by 764
Metadata
- Authors
- Saadoun, S., Waters, P., Bell, B. A., Vincent, A., Verkman, A. S., & Papadopoulos, M. C.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-01-28
- Volume
- 133
- Issue
- 2
- Pages
- 349-361
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2156918730
- Cited by
- 548
- References
- 22
- FWCI
- 32.69
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.